IMPROVED 5-YEAR RELAPSE-FREE AND TOTAL SURVIVAL AFTER RADIOTHERAPY (RT) AND ADJUVANT CVP CHEMOTHERAPY IN STAGE-I-II NON-HODGKINS LYMPHOMAS (NHL)

被引：0
|
作者：
MONFARDINI, S [1 ]
BONADONNA, G [1 ]
LATTUADA, A [1 ]
机构：
[1] IST NAZL TUMORI,I-20133 MILAN,ITALY
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1979年 / 20卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：359 / 359
页数：1
相关论文
共 18 条
  • [1] IMPROVED 5 YEAR SURVIVAL AFTER COMBINED RADIOTHERAPY-CHEMOTHERAPY FOR STAGE-I-II NON-HODGKINS LYMPHOMA
    MONFARDINI, S
    BANFI, A
    BONADONNA, G
    RILKE, F
    MILANI, F
    VALAGUSSA, P
    LATTUADA, A
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1980, 6 (02): : 125 - 134
  • [2] RADIOTHERAPY (RT) VERSUS RT + CHEMOTHERAPY (CT) IN STAGE I-II NON-HODGKINS LYMPHOMAS (NHL)
    NISSEN, NI
    ERSBOLL, J
    HANSEN, HS
    WALBOMJORGENSEN, S
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 194 - 194
  • [3] COMBINED MODALITY TREATMENT FOR STAGE-I-II NON-HODGKINS LYMPHOMAS - CVP VERSUS BACOP CHEMOTHERAPY
    BAJETTA, E
    VALAGUSSA, P
    BONADONNA, G
    LATTUADA, A
    BUZZONI, R
    RILKE, F
    BANFI, A
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1988, 15 (01): : 3 - 12
  • [4] CRITIQUE OF IMPROVED 5-YEAR SURVIVAL AFTER COMBINED RADIOTHERAPY-CHEMOTHERAPY FOR STAGE I-II NON-HODGKINS LYMPHOMA
    EARLE, JD
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1980, 6 (09): : 1276 - 1276
  • [5] COMBINED RT-CHEMOTHERAPY (CVP VS BACOP) IN PS I-II DIFFUSE NON-HODGKINS LYMPHOMAS (NHL)
    BAJETTA, E
    BUZZONI, R
    BONADONNA, G
    CANETTA, R
    MILANI, F
    VALAGUSSA, P
    LATTUADA, A
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 522 - 522
  • [6] CONTROLLED-STUDY WITH RADIOTHERAPY (RT) VS RT PLUS CVP IN STAGE I-II NON-HODGKINS LYMPHOMAS
    MONFARDINI, S
    LATTUADA, A
    MILANI, F
    BANFI, A
    BONADONNA, G
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 283 - 283
  • [7] A RANDOMIZED STUDY OF RADIOTHERAPY VERSUS RADIOTHERAPY PLUS CHEMOTHERAPY IN STAGE I-II NON-HODGKINS LYMPHOMAS
    NISSEN, NI
    ERSBOLL, J
    HANSEN, HS
    WALBOMJORGENSEN, S
    PEDERSENBJERGAARD, J
    HANSEN, MM
    RYGARD, J
    CANCER, 1983, 52 (01) : 1 - 7
  • [8] RADIOTHERAPY (RT) VS RT + CHEMOTHERAPY (CT) IN THE TREATMENT OF STAGE-I-III NON-HODGKINS LYMPHOMA (NHL) - A RANDOMIZED STUDY
    GOMEZ, GA
    AGGARWAL, KK
    PANAHON, A
    MOAYERI, H
    HENDERSON, E
    PLAGER, J
    SHIMAOKA, K
    HAN, T
    STUTZMAN, L
    NAEHER, C
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 513 - 513
  • [9] Adjuvant Chemotherapy Does Not Affect Relapse-Free Survival in Patients with Stage II & III Rectal Cancer After Neoadjuvant Chemoradiation and Total Mesorectal Excision
    Voss, R. K.
    Klaristenfeld, D. D.
    Lin, J. C.
    Ruan, J. H.
    Tseng, W. H.
    Al-Temimi, M. H.
    Tam, M. S.
    Sherman, M. J.
    Tomassi, M. J.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S22 - S23
  • [10] IMPROVED SURVIVAL FOLLOWING COMBINED RADIATION-THERAPY AND CHEMOTHERAPY FOR UNFAVORABLE PROGNOSIS STATE I-II NON-HODGKINS LYMPHOMAS
    MAUCH, P
    LEONARD, R
    SKARIN, A
    ROSENTHAL, D
    COME, S
    CHAFFEY, J
    HELLMAN, S
    CANELLOS, G
    JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (10) : 1301 - 1308
12